Elefante Mark B Invests $5.37 Million in Danaher Corporation $DHR

Elefante Mark B purchased a new stake in shares of Danaher Corporation (NYSE:DHR) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 28,204 shares of the conglomerate’s stock, valued at approximately $5,372,000. Danaher accounts for approximately 2.3% of Elefante Mark B’s portfolio, making the stock its 19th largest position.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Sivia Capital Partners LLC boosted its position in shares of Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares in the last quarter. First Trust Advisors LP boosted its holdings in Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after acquiring an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC boosted its holdings in Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after acquiring an additional 886 shares in the last quarter. Ieq Capital LLC grew its stake in shares of Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after acquiring an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC increased its holdings in shares of Danaher by 30.7% during the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after acquiring an additional 325 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DHR. HSBC lowered their price target on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Royal Bank Of Canada lifted their target price on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. DZ Bank began coverage on shares of Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target on the stock. Piper Sandler initiated coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target for the company. Finally, Wells Fargo & Company decreased their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Trading Up 0.3%

Shares of DHR stock opened at $219.42 on Monday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The firm’s 50 day moving average is $195.80 and its 200 day moving average is $192.40. The stock has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the firm earned $0.77 EPS. The company’s revenue was up 5.5% compared to the same quarter last year. Research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.